# 'Breakthrough' mRNA cancer drug curbs melanoma recurrence in large trial

https://mins.news/en/video/28227

- France 24 English, 2026-08-21 09:40 UTC
- Health
- Original: https://www.youtube.com/watch?v=Hv4aaxZ90pE

> Merck and Moderna said a personalised cancer treatment reduced the recurrence of melanoma tumours in a late-stage trial. Experts called the result a breakthrough, marking the first positive outcome for an mRNA cancer drug in a large, late-stage clinical study.

## Related coverage

- [Merck and Moderna’s personalized cancer vaccine success opens new melanoma treatment avenue](https://mins.news/en/item/28563) — CNN, 2026-08-21
- ['Breakthrough' mRNA cancer drug curbs melanoma in large trial](https://mins.news/en/item/28210) — France 24, 2026-08-21
- [Moderna, Merck say mRNA treatment cuts melanoma recurrence, spread risk](https://mins.news/en/video/27354) — CNA, 2026-08-20
- [Moderna and Merck unveil mRNA cancer vaccine that cuts melanoma spread](https://mins.news/en/item/26640) — Al Jazeera, 2026-08-19
- [Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success](https://mins.news/en/item/26437) — Bloomberg News, 2026-08-19
- [Merck, Moderna Melanoma Vaccine Study Succeeds](https://mins.news/en/video/26246) — Bloomberg Television, 2026-08-19
- [Moderna-Merck combination succeeds in late-stage skin cancer trial](https://mins.news/en/item/26142) — CNN, 2026-08-19